MedPath

Afbouw strategieën bij door anti-TNF&MTX geïnduceerde remissie bij Reumatoïde Arthritis. Moeten we MTX of anti-TNF als eerste afbouwen?

Completed
Conditions
Rheumatoid Arthritis
Registration Number
NL-OMON21808
Lead Sponsor
Erasmus MC, Rotterdam
Brief Summary

DOI: 10.1136/annrheumdis-2018-214970

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
355
Inclusion Criteria

1. RA patients;

2. Aged >17 years;

Exclusion Criteria

1. Not being able to understand, speak and write in Dutch;

2. Being diagnosed with a psychiatric or personality disorder.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath